Logo Lanfrica

Cefotaxime and ceftazidime-resistant Escherichia coli isolate producing TEM-15 β-lactamase from a Tunisian hospital

Domaine:

healthcare

Type de record:

paper
Créateur:
CheNahAriOmr
Éditeur:
Mat
Hôte:
A clinical isolate of Escherichia coli LBT04 was found to have a high-level resistance to broad-spectrum β-lactams. Analysis of this strain by the disk diffusion test revealed synergies between clavulanic acid and ceftazidime, cefotaxime. Clavulanic acid decreased the MICs of ceftazidime, cefotaxime, and ceftriaxone, which suggested that LBT04 produced an extended-spectrum β-lactamase. These resistances were carried by a 1080-bp chromosomal gene that encoded a β-lactamase with a pI of 6.3. Cloning and sequencing experiments showed that this β-lactamase revealed identity with the bla TEM-1 gene encoding the TEM-1 β-lactamase, except for a replacement of the Glu residue at position 104 by Lys, and of the Gly residue at position 238 by Ser. These two mutations were encountered in TEM-15 β-lactamase, but this is the first description of this enzyme in the E. coli species in Tunisian hospitals.

Languages

Similaires